When is sclerotherapy indicated for the treatment of venous insufficiency?

Updated: Oct 22, 2018
  • Author: Robert Weiss, MD; Chief Editor: William D James, MD  more...
  • Print

Sclerotherapy is performed by injecting or infusing a sclerosing substance into the refluxing vessel to produce endothelial destruction and fibrosis of the treated vessel. Injection of a sclerosing agent directly into veins usually is reserved for telangiectatic lesions rather than CVI. Phlebotonics have not been proven to be beneficial for CVI. [32]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!